I've received quite alot of emails over the past few days with regards to Sutent. Inquires about what I may know about this chemo drug.
So I have decided to write today's post to seek your views, ask your questions and make comments about your experiences with Sutent.
Hopefully other viewers will obtain the information they are seeking and together, by sharing our experiences and knowledge, it will most of all provide some resolution to all of our questions.
To ask your questions and review what others are revealing about Sutent, you have two choices:
1) Use the "live chat" forum at the top of this page. All you have to do is enter your name or some other identity that you may wish to choose in the "Anonymous" area of the chat screen. Press enter. Then you can type your questions or remarks in the blank area at the bottom of the chat screen. Press "enter" once again and you should see your words appear. Maybe someone will reply immediately if another viewer happens to be on at the same time. You can always review whatever has been entered on the chat, by checking the "archived" feature. Most of us usually connect approximately 7:30 ADT or a little later for a live chat, so you are always welcome to join in. Maybe you'll meet another viewer and arrange a chat time that is convenient to both of you. Remember, this is a live chat, so you have the advantage here of receiving immediate responses.
2) If you are not familiar with the chat process, just post your question or remarks in the "Comment" section at the end of this post. These posts can be read by everyone later, and if you'd like to respond to a particular one, then everyone will have access to read it at their own convenient time.
We are beginning to have a loyal following of cancer patients, caregivers, family and friends. All are very welcome. Although my website address appears to be specifically for kidney cancer patients, we like to hear from everyone. It is my hope that together each of you will find encouragement and inspiration when it is needed most.